<DOC>
	<DOCNO>NCT02387788</DOCNO>
	<brief_summary>Phase 2a open-label study ass efficacy safety subcutaneous 15mg AKB-9778 administer twice daily 84 day subject macular edema due RVO .</brief_summary>
	<brief_title>Open Label Study Assess Efficacy Safety AKB-9778 Subjects With Macular Edema Due RVO</brief_title>
	<detailed_description>Subjects participate study 168 day . Up 20 subject enrol study . Subjects self-administer study medication subcutaneous ( SC ) injection abdomen ( preferably ) twice per day ; first dose day administer morning evening dose administer within 8 16 hour morning dose . Safety assessment conduct study visit treatment AEs collect throughout Treatment period 56-days observation period visit .</detailed_description>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<criteria>The following abbreviated list Definite retinal thickening due RVO involve central macula base Investigator 's clinical evaluation demonstrate sdOCT . Mean central subfield thickness least 300 µm sdOCT presence intraretinal fluid ETDRS BCVA letter score ≤ 76 ≥ 24 . Decrease vision determine primarily result macular dema due RVO due cause . The following abbreviated list Macular edema consider due cause RVO Any ocular disease may cause substantial reduction visual acuity , include iris neovascularization , retinal detachment , epiretinal membrane , vitreous hemorrhage fibrosis , ocular inflammation ( uveitis ) , retinal inflammatory , infectious disease , primary openangle glaucoma . High myopia ( 8 diopter correction ) . History idiopathic autoimmune uveitis . History ocular surgery within 3 month prior Day 1 . History panretinal scatter photocoagulation ( PRP ) focal laser within 3 month prior Day 1 . History prior intravitreal , subtenon , periocular steroid therapy within 3 month prior Day 1 ( e.g. , triamcinolone ) . History prior treatment intravitreal antiVEGF treatment within 16 week prior Day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>